These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9579798)

  • 1. A novel and efficient method for synthetic carbohydrate conjugate vaccine preparation: synthesis of sialyl Tn-KLH conjugate using a 4-(4-N-maleimidomethyl) cyclohexane-1-carboxyl hydrazide (MMCCH) linker arm.
    Ragupathi G; Koganty RR; Qiu D; Lloyd KO; Livingston PO
    Glycoconj J; 1998 Mar; 15(3):217-21. PubMed ID: 9579798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells.
    Ragupathi G; Howard L; Cappello S; Koganty RR; Qiu D; Longenecker BM; Reddish MA; Lloyd KO; Livingston PO
    Cancer Immunol Immunother; 1999 Apr; 48(1):1-8. PubMed ID: 10235483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies.
    Ragupathi G; Deshpande PP; Coltart DM; Kim HM; Williams LJ; Danishefsky SJ; Livingston PO
    Int J Cancer; 2002 May; 99(2):207-12. PubMed ID: 11979435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis.
    Longenecker BM; Reddish M; Koganty R; MacLean GD
    Adv Exp Med Biol; 1994; 353():105-24. PubMed ID: 7527178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses of mice and human breast cancer patients following immunization with synthetic sialyl-Tn conjugated to KLH plus detox adjuvant.
    Longenecker BM; Reddish M; Koganty R; MacLean GD
    Ann N Y Acad Sci; 1993 Aug; 690():276-91. PubMed ID: 7690215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine.
    MacLean GD; Reddish MA; Koganty RR; Longenecker BM
    J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):59-68. PubMed ID: 8859725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model.
    Song C; Zheng XJ; Liu CC; Zhou Y; Ye XS
    Oncotarget; 2017 Jul; 8(29):47330-47343. PubMed ID: 28537884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients.
    Adluri S; Helling F; Ogata S; Zhang S; Itzkowitz SH; Lloyd KO; Livingston PO
    Cancer Immunol Immunother; 1995 Sep; 41(3):185-92. PubMed ID: 7553688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for the clinical development of STn-KLH (Theratope) and anti-MUC-1 vaccines in breast cancer.
    Miles D; Papazisis K
    Clin Breast Cancer; 2003 Feb; 3 Suppl 4():S134-8. PubMed ID: 12620150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialyl-Tn-KLH, glycoconjugate analysis and stability by high-pH anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD).
    Jorge P; Abdul-Wajid A
    Glycobiology; 1995 Dec; 5(8):759-64. PubMed ID: 8720073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical development of the STn-KLH vaccine (Theratope).
    Ibrahim NK; Murray JL
    Clin Breast Cancer; 2003 Feb; 3 Suppl 4():S139-43. PubMed ID: 12620151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a mouse monoclonal IgG3 antibody to the tumor-associated globo H structure produced by immunization with a synthetic glycoconjugate.
    Kudryashov V; Ragupathi G; Kim IJ; Breimer ME; Danishefsky SJ; Livingston PO; Lloyd KO
    Glycoconj J; 1998 Mar; 15(3):243-9. PubMed ID: 9579801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine.
    Slovin SF; Ragupathi G; Musselli C; Olkiewicz K; Verbel D; Kuduk SD; Schwarz JB; Sames D; Danishefsky S; Livingston PO; Scher HI
    J Clin Oncol; 2003 Dec; 21(23):4292-8. PubMed ID: 14645418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumors.
    Keding SJ; Danishefsky SJ
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):11937-42. PubMed ID: 15280546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers.
    Ragupathi G; Koide F; Sathyan N; Kagan E; Spassova M; Bornmann W; Gregor P; Reis CA; Clausen H; Danishefsky SJ; Livingston PO
    Cancer Immunol Immunother; 2003 Oct; 52(10):608-16. PubMed ID: 12811527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines.
    Wu J; Guo Z
    Bioconjug Chem; 2006; 17(6):1537-44. PubMed ID: 17105234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine.
    Zhu J; Wan Q; Lee D; Yang G; Spassova MK; Ouerfelli O; Ragupathi G; Damani P; Livingston PO; Danishefsky SJ
    J Am Chem Soc; 2009 Jul; 131(26):9298-303. PubMed ID: 19518111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines.
    Pan Y; Chefalo P; Nagy N; Harding C; Guo Z
    J Med Chem; 2005 Feb; 48(3):875-83. PubMed ID: 15689172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic and immunological studies of N-acyl modified S-linked STn derivatives as anticancer vaccine candidates.
    Huo CX; Zheng XJ; Xiao A; Liu CC; Sun S; Lv Z; Ye XS
    Org Biomol Chem; 2015 Mar; 13(12):3677-90. PubMed ID: 25679360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allylmalonamide as a bivalent linker: synthesis of biantennary GM3-saccharide--keyhole limpet hemocyanin glycoconjugate and the immune response in mice.
    Zou W; Abraham M; Gilbert M; Wakarchuk WW; Jennings HJ
    Glycoconj J; 1999 Sep; 16(9):507-15. PubMed ID: 10815987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.